Figure 3.

Increased percentages of IL-17+ CD4+ T cells and IL-17+ CD8+ T cells in PBMCs from SLE patients. (a, c) The percentages of IL-17+ CD4+ T cells (a) or IL-17+ CD8+ T cells (c) in PBMCs from inactive and active SLE patients, psoriatic patients and normal subjects on Day 0 (left panel) and Day 3 (right panel) are shown. The horizontal bars show the mean values. (b, d) The fold increase in the percentages of IL-17+ CD4+ T cells (b) and IL-17+ CD8+ T cells (d) in PBMCs from inactive and active SLE patients, psoriatic patients and normal subjects is shown. The percentages of IL-17+ T cells at Day 3 were divided by those of Day 0 from individual samples and the results were presented as fold increase. The horizontal bars show the mean values.

Puwipirom et al. Arthritis Research & Therapy 2010 12:R215   doi:10.1186/ar3194
Download authors' original image